Emerald Mutual Fund Advisers Trust Eloxx Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$3.19 - $7.56 $463,905 - $1.1 Million	-145,425 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$4.37 - $9.91 $238,492 - $540,838	-54,575 Reduced 27.29%	145,425 $657,000
Q2 2018 Jul 31, 2018	BUY	$8.75 - $23.27 $1.75 Million - $4.65 Million	200,000 New	200,000 $3.41 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.